Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone 2EB9Q). We employs the Lentivirus (T7-GFP-AR-KpnI) vector components and the SynExpress system of the miRNA Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DR5
Clone
2EB9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
AR
Insertion Sites
KpnI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
Lentivirus
Transformation Accuracy
0.85
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.